GPER regulation and functions have also been involved in the resistance to tamoxifen in breast tumor patients, thus therapeutic approaches targeting the GPER-mediated signaling may be taken into account in setting innovative pharmacological strategies, in particular to hamper the failure of classical anti-estrogens in breast malignancy. The gene discussed is GPER1; the disease is breast neoplasm.